GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of US ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

Gepotidacine is not the only new oral antibiotic for gonorrhoea that researchers are exploring. Another, called zoliflodacin, ...

Scientists have found the first new antibiotic treatment for gonorrhoea since the 1990s amid fears over the rise of ...

In recent years, LinkedIn has become seemingly overrun with would-be influencers humble-bragging about their own achievements ...

Justin Verlander is living an affluent lifestyle owing to humongous earnings he made from his 22-season-long baseball career. The 2011 MVP has built v ...

With a target of 10,000 participants, this year's Gabii sa Kabilin (GSK) 2025 honors the power of youth in shaping culture and history, as it returns for its 18th year.

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

Health Secretary Robert F. Kennedy Jr., who has often linked vaccines to the neurodevelopmental disorder autism, said ...

New research reveals that the immune checkpoint molecule Tim-3 plays a critical role in how microglia, the brain’s immune cells, respond to Alzheimer’s disease.